ICICI Prudential Nifty Pharma Index Fund Regular Growth
- Index Funds
- Index Funds
- Very High Risk
Rating:
Key Metrics
Aum
₹135.94 Cr
Expense Ratio
0.89%
Exit Load
0.00%
Min. Investment
₹1,000.00
Min. SIP
₹1000.00
Launch Date
15 Dec 2022
CAGR Returns
| Period | Absolute(%) | Annualised(%) |
|---|---|---|
| 1 Month | +6.72% | -- |
| 3 Months | +16.22% | -- |
| 6 Months | +20.74% | -- |
| 1 Year | +15.27% | +15.27% |
| 2 Years | -- | +12.57% |
| 3 Years | +79.3% | +21.49% |
| 5 Years | -- | 0% |
| Since Launch | +98.57% | +21.01% |
Holdings as on 22 Jul 2026
| Name | Value (₹Cr) | Holding % |
|---|---|---|
| Sun Pharmaceutical Industries | 28.98 | 21.31 |
| Divi's Laboratories | 12.29 | 9.04 |
| Dr Reddy's Laboratories | 12.16 | 8.94 |
| Cipla | 12.12 | 8.91 |
| Laurus Labs | 8.68 | 6.38 |
| Lupin | 8.64 | 6.35 |
| Torrent Pharmaceuticals | 7.13 | 5.24 |
| Aurobindo Pharma | 6.43 | 4.72 |
| Glenmark Pharmaceuticals | 4.88 | 3.59 |
| Alkem Laboratories | 4.79 | 3.52 |
Morning Star Rating
Rating:
Risk
Return
Risk & Volitility
0.91
Sharpe Ratio
16.43%
Std. Deviation
--
Tracking Error
--
Alpha
--
Beta
Peer Comparison
| Fund Name | 1Y | 3Y | 5Y |
|---|---|---|---|
| ICICI Prudential Nifty Pharma Index Fund Regular Growth | +14.56% | +21.33% | -- |
| UTI Nifty50 Equal Weight Index Fund Regular Growth | +4.95% | +12.61% | -- |
| Edelweiss Nifty 100 Quality 30 Index Fund Regular Growth | -0.36% | +8.38% | -- |
| Sundaram Nifty 100 Equal Wgt Gr | +5.79% | +14.91% | +12.95% |
| Groww Nifty Smallcap 250 Index Fund Regular Growth | +0.31% | -- | -- |
Results are calculated on CAGR basis
About Fund
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
The ICICI Prudential Nifty Pharma Index Fund Regular Growth has an AUM of 135.94 crores & has delivered CAGR of 0.00 in the last 5 years. The fund has an exit load of 0.00% and an expense ratio of 0.89%. The minimum investment in ICICI Prudential Nifty Pharma Index Fund Regular Growth is Rs 1000 and the minimum SIP is Rs 1000.
As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.
The fund has a present cash holding of %. The top holdings of the fund include Sun Pharmaceutical Industries, Divi's Laboratories, Dr Reddy's Laboratories, Cipla.
The major sectors where the fund is invested are Biotechnology & Drugs, Major Drugs.
Some of the similar funds are ICICI Prudential Nifty Pharma Index Fund Regular Growth, UTI Nifty50 Equal Weight Index Fund Regular Growth, Edelweiss Nifty 100 Quality 30 Index Fund Regular Growth, Sundaram Nifty 100 Equal Wgt Gr, Groww Nifty Smallcap 250 Index Fund Regular Growth. ICICI Prudential Nifty Pharma Index Fund Regular Growth has a sharpe ratio of 0.91 & a standard deviation of 16.43%.
FAQs
According to the morning star rating ICICI Prudential Nifty Pharma Index Fund Regular Growth has a Medium risk & Exceptional return.
ICICI Prudential Nifty Pharma Index Fund Regular Growth is managed by Nishit Patel,Ashwini Bharucha,Venus Ahuja.
The expense ratio of ICICI Prudential Nifty Pharma Index Fund Regular Growth is 0.89%.
The 5 year annualized return on ICICI Prudential Nifty Pharma Index Fund Regular Growth is 0.00% & it has generated 15.27% in the last 1 year.
The minimum investment in ICICI Prudential Nifty Pharma Index Fund Regular Growth is 1000 Rs.
ICICI Prudential Nifty Pharma Index Fund Regular Growth has an AUM of 135.94 crores.
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.